UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

The Journal of immunology (1950), 2009-11, Vol.183 (10), p.6186-6197

2009

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1920-1930

2014

Link zum Volltext

Verfügbarkeit prüfen

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys

Frontiers in immunology, 2020-11, Vol.11, p.579872-579872

2020

Link zum Volltext

Verfügbarkeit prüfen

An Antigenic Peptide Produced by Peptide Splicing in the Proteasome

Science (American Association for the Advancement of Science), 2004-04, Vol.304 (5670), p.587-590

2004

Link zum Volltext

Verfügbarkeit prüfen

The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases

The Journal of immunology (1950), 2002-10, Vol.169 (8), p.4161-4171

2002

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity

Vaccine, 2011-03, Vol.29 (13), p.2461-2473

2011

Link zum Volltext

Verfügbarkeit prüfen

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

Vaccine, 2006-08, Vol.24 (33), p.5937-5949

2006

Link zum Volltext

Verfügbarkeit prüfen

Ethical approval for controlled human infectious model clinical trial protocols – A workshop report

Biologicals, 2024-02, Vol.85, p.101748-101748, Article 101748

2024

Link zum Volltext

Verfügbarkeit prüfen

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

npj vaccines, 2017-09, Vol.2 (1), p.25-25, Article 25

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2011-08, Vol.25 (4), p.217-226

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report

Biologicals, 2024-02, Vol.85, p.101746-101746, Article 101746

2024

Link zum Volltext

Verfügbarkeit prüfen

Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation

Journal of Immunology, 2006-01, Vol.176 (2), p.1053-1061

2006

Link zum Volltext

Verfügbarkeit prüfen

Production of an antigenic peptide by insulin-degrading enzyme

Nature immunology, 2010-05, Vol.11 (5), p.449

2010

Link zum Volltext

Verfügbarkeit prüfen

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

Current Opinion in Immunology, 2001-04, Vol.13 (2), p.147-153

2001

Link zum Volltext

Verfügbarkeit prüfen

Induction of Bordetella pertussis -specific immune memory by DTPa vaccines

Vaccine, 2011-04, Vol.29 (18), p.3449-3455

2011

Link zum Volltext

Verfügbarkeit prüfen

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

Immunity (Cambridge, Mass.), 2000-01, Vol.12 (1), p.107-117

2000

Link zum Volltext

Verfügbarkeit prüfen

Reply to the letter by Dr. Stanley Plotkin

Vaccine, 2011-12, Vol.29 (52), p.9581-9581

2011

Link zum Volltext

Verfügbarkeit prüfen

Induction ofBordetella pertussis-specific immune memory by DTPa vaccines

Vaccine, 2011-04, Vol.29 (18), p.3449

2011

Link zum Volltext

Verfügbarkeit prüfen

Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5461-5468

2006

Link zum Volltext

Verfügbarkeit prüfen

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome

The Journal of experimental medicine, 2002-02, Vol.195 (4), p.391-399

2002

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant System AS03 containing [alpha]-tocopherol modulates innate immune response and leads to improved adaptive immunity

Vaccine, 2011-03, Vol.29 (13), p.2461

2011

Link zum Volltext

Verfügbarkeit prüfen

Two new tumor‐specific antigenic peptides encoded by gene MAGE‐C2 and presented to cytolytic T lymphocytes by HLA‐A2

International journal of cancer, 2004-05, Vol.109 (5), p.698-702

2004

Link zum Volltext

Verfügbarkeit prüfen

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA0201‐restricted melanoma epitopes

International immunology, 2003-12, Vol.15 (12), p.1423-1430

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys

An Antigenic Peptide Produced by Peptide Splicing in the Proteasome

The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

Ethical approval for controlled human infectious model clinical trial protocols – A workshop report

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report

Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation

Production of an antigenic peptide by insulin-degrading enzyme

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

Induction of Bordetella pertussis -specific immune memory by DTPa vaccines

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

Reply to the letter by Dr. Stanley Plotkin

Induction ofBordetella pertussis-specific immune memory by DTPa vaccines

Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome

Erratum: Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Adjuvant System AS03 containing [alpha]-tocopherol modulates innate immune response and leads to improved adaptive immunity

Two new tumor‐specific antigenic peptides encoded by gene MAGE‐C2 and presented to cytolytic T lymphocytes by HLA‐A2

Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA0201‐restricted melanoma epitopes

Suchergebnisse filtern